Clinical Trial VICCTHO0547


Molecular Fingerprints in Lung Cancer: Predicting Tumor Response to Therapy (SPORE)

Principal Investigator(s)

Christine Lovly


  • Protocol No. VICCTHO0547
  • Open Date: 12/19/2005
  • Staging: NA
  • Age Group: Adults
  • Scope: Local
  • Objective: From biopsies of lung cancer, we will determine protein and/or RNA expression patterns capable of predicting tumor response to therapy. We will then characterize which genes and proteins are found to be predictive to help elucidate the molecular biology underlying cancer chemosensitivity.
  • Disease Sites: Lung; Non Small Cell
  • Therapies: Correlative
  • Drugs: None Specified
  • Participating Institutions: Vanderbilt University
  • National Clinical Trial ID: NCT00897650
  • Secondary Protocol No: Not Specified



Learn More

You do not have JavaScript enabled. This site works better with JavaScript turned on.